← Back to Vaccine Database

SARS-CoV-2 rS/Matrix M1-Adjuvant

Protein based vaccine · VDDBV0679

Target & Classification

SARS-CoV-2SARS-CoV-2
Protein based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials8

Note: 2 additional source trials listed this vaccine in studies of unrelated viruses (e.g. as a comparator, adjunct, or in coadministration trials with other vaccines). Those trials are not shown here.

NCT IDPhaseDisease / Condition
NCT04961541 Phase 1COVID-19
NCT04368988 Phase 2COVID-19
NCT04533399 Phase 2COVID-19
NCT05112848 Phase 2COVID-19
NCT05236491 Phase 3COVID-19
NCT04611802 Phase 3COVID-19
NCT04583995 Phase 3COVID-19
NCT05249816 Phase 3COVID-19